Related Experiment Videos
[Esophageal carcinoma: downstaging or stent?]
K E Grund1, J Noetzel, C Zindel
1Allgemeinchirurgie/Chirurgische Endoskopie, Universitätskliniken Tübingen.
Langenbecks Archiv Fur Chirurgie. Supplement. Kongressband. Deutsche Gesellschaft Fur Chirurgie. Kongress
|January 1, 1996
Summary
Radio-chemotherapy offers moderate benefits but carries significant risks and poor quality of life for many patients. Further research is needed to clarify the role of surgery and optimize downstaging strategies.
Area of Science:
- Oncology
- Radiotherapy
- Chemotherapy
Context:
- Multimodal therapeutic strategies, including radio-chemotherapy, are employed for cancer treatment.
- Current approaches demonstrate variable efficacy and significant risks.
- Patient quality of life during treatment, particularly downstaging, is a concern.
Purpose:
- To evaluate the therapeutic benefits, risks, and impact on quality of life of multimodal cancer therapies.
- To assess the effectiveness of current downstaging protocols.
- To explore the role of surgery and palliative endoscopic interventions.
Summary:
- Radio-chemotherapy shows a therapeutic benefit in 10-40% of patients, with 35-80% experiencing inadequate response.
- Complication rates range from 20-70%, and quality of life during downstaging is often poor.
- Endoscopic methods like argon plasma coagulation and metal stents offer effective palliative care with low risk and high patient comfort.
Impact:
- Highlights the limitations of current multimodal therapies and the need for controlled trials in cancer downstaging.
- Emphasizes the importance of differentiated staging and monitoring of tumor manifestations.
- Identifies promising palliative endoscopic techniques for improving patient comfort and outcomes.